CALQUENCE® (acalabrutinib) HCP

Please see full Important Safety Information below in the pinned post and at Calquencehcp.com/#isi. This product information is intended for US Healthcare Professionals only. CALQUENCE is a registered trademark of AstraZeneca. It is not associated with any individual users on LinkedIn. Please see full Prescribing Information, including Patient Information, by visiting https://qr.short.az/CalquenceISI. You may report side effects related to AstraZeneca products by visiting https://us-aereporting.astrazeneca.com/adverse-events.html. US-99288 Last Updated 4/25